市場調查報告書
商品編碼
1355823
灌注系統市場 - 按技術(低溫機器灌注、常溫機器灌注)、按組件(制氧機、心肺機、灌注泵、監測系統)、按應用、按最終用途和預測,2023 - 2032 年Perfusion Systems Market - By Technique (Hypothermic Machine Perfusion, Normothermic Machine Perfusion), By Component (Oxygenators, Heart-Lung Machine, Perfusion Pumps, Monitoring System), By Application, By End-use & Forecast, 2023 - 2032 |
2023 年至 2032 年間,全球灌注系統市場的複合年成長率將達到 4.6%。心血管和呼吸系統疾病的盛行率不斷增加,器官移植和手術需要先進的灌注系統。醫療技術的進步帶來了更複雜和高效的灌注系統。 FDA 對涉及大量或與之相關的最新技術設備的批准不斷增加,支持了市場的成長。
例如,2023 年 8 月,領先的醫療技術公司 LivaNova PLC 宣布其 Essenz (TM) 線上血液監測儀 (ILBM) 獲得 FDA 和 CE 標誌的監管許可。此監視器整合到 Essenz (TM) 灌注系統中,使灌注師能夠從系統的駕駛艙方便地存取和管理血液參數,無需額外的監視器或支架。人口老化的加劇增加了器官移植的需求,進一步推動了市場的成長。此外,人們日益認知到灌注在醫療保健中的重要性以及全球器官移植計劃的擴展推動了灌注系統的市場前景。
整個灌注系統市場根據技術、應用和區域進行分類。
常溫機器灌注領域將在 2023 年至 2032 年期間經歷重大發展。這種先進技術在移植過程中在接近正常體溫的情況下保存和評估器官,從而增強其活力和功能。常溫機器灌注在移植手術中變得越來越重要,因為它可以更好地評估器官並延長成功移植的時間窗口,從而推動此類系統對灌注系統市場收入的貢獻。
細胞灌注系統部分從 2023 年到 2032 年將實現值得稱讚的複合年成長率。這些專用設備在細胞培養和組織工程應用中至關重要,為培養細胞和組織提供受控環境。研究人員和生物技術人員依靠細胞灌注系統來複製生理條件、研究細胞行為並開發先進的療法。對精確、高效的細胞灌注技術的需求持續推動灌注系統市場的成長。
歐洲灌注系統產業從 2023 年到 2032 年將呈現可觀的複合年成長率。該地區完善的醫療基礎設施和越來越多的器官移植手術推動了對先進灌注系統的需求。常溫機器灌注和創新技術在歐洲醫療保健領域日益受到重視,進一步促進了市場成長。由於專注於改善移植結果和解決器官短缺問題,歐洲仍然是醫療領域灌注系統的關鍵市場。
Global Perfusion Systems Market will witness 4.6% CAGR between 2023 and 2032. The increasing prevalence of cardiovascular and respiratory diseases necessitates advanced perfusion systems for organ transplants and surgeries. Advancements in medical technology have led to more sophisticated and efficient perfusion systems. Rising FDA approvals for the latest technological devices involving or associated with profusions support market growth.
For instance, in August 2023, LivaNova PLC, a leading medical technology company, announced the attainment of regulatory clearances from the FDA and CE Mark for its Essenz™ In-Line Blood Monitor (ILBM). Integrated into the Essenz™ Perfusion System, the monitor enables perfusionists to access and manage blood parameters conveniently from the system's cockpit, eliminating the need for extra monitors or holders. The rising aging population contributes to the demand for organ transplantation, further fueling market growth. Additionally, the growing awareness of the importance of perfusion in healthcare and the expansion of organ transplant programs globally drive the perfusion systems market outlook.
The overall Perfusion Systems Market is classified based on technique, application, and region.
The normothermic machine perfusion segment will undergo significant development from 2023 to 2032. This advanced technique preserves and evaluates organs at near-normal body temperatures during transplantation, enhancing their viability and functionality. Normothermic machine perfusion is becoming increasingly crucial in transplant procedures, as it allows for better organ assessment and extends the window of time for successful transplantation, driving the contribution of such systems in the perfusion systems market revenue.
The cell perfusion system segment will register a commendable CAGR from 2023 to 2032. These specialized devices are vital in cell culture and tissue engineering applications, providing a controlled environment for nurturing cells and tissues. Researchers and biotechnologists rely on cell perfusion systems to replicate physiological conditions, study cell behavior, and develop advanced therapies. The demand for precise and efficient cell perfusion technology continues to drive the perfusion systems market growth.
Europe Perfusion Systems Industry will showcase an appreciable CAGR from 2023 to 2032. The region's well-established healthcare infrastructure and a growing number of organ transplant procedures drive the need for advanced perfusion systems. Normothermic machine perfusion and innovative technologies are gaining prominence in European healthcare, further contributing to market growth. With a focus on improving transplant outcomes and addressing organ shortages, Europe remains a pivotal market for perfusion systems in the medical field.